Free Trial
NASDAQ:KLTO

Klotho Neurosciences (KLTO) Stock Price, News & Analysis

Klotho Neurosciences logo
$0.18 -0.01 (-3.55%)
As of 05/30/2025 04:00 PM Eastern

About Klotho Neurosciences Stock (NASDAQ:KLTO)

Key Stats

Today's Range
$0.18
$0.19
50-Day Range
$0.13
$0.29
52-Week Range
$0.11
$8.11
Volume
615,403 shs
Average Volume
7.17 million shs
Market Capitalization
$6.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Receive KLTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Klotho Neurosciences and its competitors with MarketBeat's FREE daily newsletter.

KLTO Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Klotho Neurosciences faces Nasdaq delisting risk
Klotho Neurosciences, Inc. (KLTO)
Klotho Neuroscience Inc (KLTO)
See More Headlines

KLTO Stock Analysis - Frequently Asked Questions

Klotho Neurosciences' stock was trading at $0.4850 at the beginning of the year. Since then, KLTO shares have decreased by 61.9% and is now trading at $0.1847.
View the best growth stocks for 2025 here
.

Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced its quarterly earnings data on Thursday, May, 15th. The company reported ($0.08) EPS for the quarter.

Shares of KLTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
5/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KLTO
Previous Symbol
NASDAQ:KLTO
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.35 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.19 per share
Price / Cash Flow
0.95
Book Value
($2.16) per share
Price / Book
-0.09

Miscellaneous

Free Float
26,539,000
Market Cap
$6.00 million
Optionable
N/A
Beta
-1.10
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:KLTO) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners